Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease

被引:325
作者
Veldhoen, Marc [1 ]
Hocking, Richard J. [1 ]
Flavell, Richard A. [1 ]
Stockinger, Brigitta [1 ]
机构
[1] Natl Inst Med Res, MRC, London NW7 1AA, England
基金
英国医学研究理事会;
关键词
D O I
10.1038/ni1391
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is unclear whether TGF-beta, a critical differentiation factor for T cells producing interleukin 17 ( T-H-17 cells), is required for the initiation of experimental autoimmune encephalomyelitis ( EAE) in vivo. Here we show that mice whose T cells cannot respond to TGF-b signaling lack T-H-17 cells and do not develop EAE despite the presence of T helper cell type 1 infiltrates in the spinal cord. Local but not systemic antibody blockade of TGF-beta prevented T-H-17 cell differentiation and the onset of EAE. The pathogen stimulus zymosan, like mycobacterium, induced T-H-17 cells and initiated EAE, but the disease was transient and correlated with reduced production of interleukin 23. These data show that TGF-beta is essential for the initiation of EAE and suggest that disease progression may require ongoing chronic inflammation and production of interleukin 23.
引用
收藏
页码:1151 / 1156
页数:6
相关论文
共 53 条
  • [1] Osteopontin is not required for the development of Th1 responses and viral immunity
    Abel, B
    Freigang, S
    Bachmann, MF
    Boschert, U
    Kopt, M
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (09) : 6006 - 6013
  • [2] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [3] CONTROL OF ESTABLISHED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY INHIBITION OF TUMOR-NECROSIS-FACTOR (TNF) ACTIVITY WITHIN THE CENTRAL-NERVOUS-SYSTEM USING MONOCLONAL-ANTIBODIES AND TNF RECEPTOR IMMUNOGLOBULIN FUSION PROTEINS
    BAKER, D
    BUTLER, D
    SCALLON, BJ
    ONEILL, JK
    TURK, JL
    FELDMANN, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) : 2040 - 2048
  • [4] Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
    Becher, B
    Durell, BG
    Noelle, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) : 493 - 497
  • [5] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [6] Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849
  • [7] Cautain B, 2001, EUR J IMMUNOL, V31, P1132, DOI 10.1002/1521-4141(200104)31:4<1132::AID-IMMU1132>3.3.CO
  • [8] 2-E
  • [9] The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
    Chabas, D
    Baranzini, SE
    Mitchell, D
    Bernard, CCA
    Rittling, SR
    Denhardt, DT
    Sobel, RA
    Lock, C
    Karpuj, M
    Pedotti, R
    Heller, R
    Oksenberg, JR
    Steinman, L
    [J]. SCIENCE, 2001, 294 (5547) : 1731 - 1735
  • [10] Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
    Chen, Y
    Langrish, CL
    Mckenzie, B
    Joyce-Shaikh, B
    Stumhofer, JS
    McClanahan, T
    Blumenschein, W
    Churakovsa, T
    Low, J
    Presta, L
    Hunter, CA
    Kastelein, RA
    Cua, DJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) : 1317 - 1326